Skip to main content
OpenTrials
Completed

NCT Number: NCT02624011

Influence of Sedentary Time on Skeletal Muscle Protein Metabolism

This study will investigate the influence of increased sedentary time on long-term measures of muscle protein synthesis and metabolic health. The investigators will test the hypothesis that increased time spent in sedentary behaviours will lead to a reduction in long-term measures of muscle protein synthesis and compromised metabolic health.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

School of Sport Exercise and Rehabilitation Sciences, University of Birmingham

Birmingham, B15 2TT, United Kingdom

About this study

Sarcopenia, the loss of muscle mass with age, is thought to be accelerated by an inactive, sedentary lifestyle. Increased sedentary time has consistently been associated with lower muscle mass and compromised metabolic health. However, there is currently a lack of direct evidence to support these associations.

Therefore, this study will investigate whether increased sedentary time (reduced step count and exercise cessation) directly influences long-term measures of muscle protein synthesis and metabolic health in young, active adults. Following a 7 day period of normal habitual physical activity, participants will undertake a 7 day period of step reduction and exercise cessation. It is hypothesised that 7 days of increased sedentary time will result in a reduction in long-term rates of muscle protein synthesis and a worsening of metabolic health.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Body mass index (18.5-29.99 kg/m2)
  • Active - defined as: ≥ 7000 steps per day (assessed during screening) and taking part in regular exercise (defined as participation in ≥ 3 sessions of aerobic and/or resistance exercise type sessions a week for ≥ 6 months prior to recruitment)
  • Good general health

Exclusion criteria

  • Lidocaine allergy
  • Hypertension (≥140/90 mmHg)
  • Current participation in another clinical study
  • Previous participation in this study
  • Bleeding disorder/s
  • Current or recent smoker
  • Past history of substance abuse and/or taking prescription or non-prescription medication (e.g., beta-blockers, insulin or thyroxine) or supplements that may influence normal metabolic responses.
  • Participants who have previously (within 5 years of the present study) had 4 or more muscle biopsies obtained from the thigh quadriceps region will be ineligible.

Treatment and study plan

7 days of habitual physical activity followed by 7 days of reduced physical activity

Behavioral

Young, active participants will undergo a 7 day period of habitual physical activity followed by a 7 day period of step reduction and exercise cessation.

Primary outcomes

  1. Muscle protein synthesis (FSR %/day)

    Time frame: 0-14 days

    Long-term muscle protein synthesis (FSR %/day) will be determined using deuterium oxide (D2O) to compare muscle protein synthesis rates over the first 7 day period and the second 7 day period.

Secondary outcomes

  1. Rate of fat oxidation at rest (g/min)

    Time frame: For 20 minutes at day 7 and day 14

    Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) at rest will be measured using indirect calorimetry to calculate the rate of fat oxidation at rest (g/min).

  2. Rate of fat oxidation during an oral glucose tolerance test (g/min)

    Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14

    Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) following an oral glucose drink will be measured using indirect calorimetry to calculate the rate of fat oxidation during an oral glucose tolerance test (g/min).

  3. Rate of carbohydrate oxidation at rest (g/min)

    Time frame: For 20 minutes at day 7 and day 14

    Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) at rest will be measured using indirect calorimetry to calculate the rate of carbohydrate oxidation at rest (g/min).

  4. Rate of carbohydrate oxidation during an oral glucose tolerance test (g/min)

    Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14

    Whole body oxygen consumption (VO2, L/min) and carbon dioxide production (VCO2, L/min) following an oral glucose drink will be measured using indirect calorimetry to calculate the rate of carbohydrate oxidation during an oral glucose tolerance test (g/min).

  5. Blood glucose concentration

    Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14

    Blood glucose concentration will be assessed in blood samples taken during the oral glucose tolerance test.

  6. Blood insulin concentration

    Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14

    Blood insulin concentration will be assessed in blood samples taken during the oral glucose tolerance test.

  7. Blood fatty acid concentration

    Time frame: At 0, 30, 60, 90 and 120min of the oral glucose tolerance test at day 7 and day 14

    Blood fatty acid concentration will be assessed in blood samples taken during the oral glucose tolerance test.

Sponsors and collaborators

Lead sponsor

University of Birmingham

Other

Collaborators

  • Maastricht University

Registry information

Official study title

Influence of Increased Sedentary Time on Long-term Rates of Skeletal Muscle Protein Synthesis in Young Adults

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Dec 8, 2015
Registry last updated
Oct 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.